Skip to content

Effectiveness of Acupuncture Treatment Applied in Addition to the Rehabilitation Program in Multiple Sclerosis Patients

Effectiveness of Acupuncture Treatment Applied in Addition to the Rehabilitation Program in Multiple Sclerosis Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06178029
Enrollment
40
Registered
2023-12-20
Start date
2023-06-18
Completion date
2024-04-15
Last updated
2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

Acupuncture, Gait, Fatigue

Brief summary

The purpose of the study is to assess the effect of acupuncture treatment combinated with conventional rehabilitation methods on gait, fatigue, quality of life and bladder functions in patients with multiple sclerosis

Detailed description

After being informed about study and potential risks, all patient giving written informed consent will undergo screening period determine eligibility for study entry. The patients who meet the eligibility recruitments will get treatment into two groups in a conventional rehabilitation and acupuncture combined with conventional rehabilitation

Interventions

OTHERAcupuncture

20 patients with multiple sclerosis meeting the criteria will undergo conventional rehabilitation and acupuncture treatment.

OTHERConventional Rehabilitation

20 patients with multiple sclerosis meeting the criteria will undergo conventional rehabilitation

Sponsors

Ankara City Hospital Bilkent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Being diagnosed with MS according to McDonald criteria * EDSS score between 1-6 * The patient is clinically stable * Having not had a new MS attack in the last 3 months * Being cognitively suitable to participate in the study

Exclusion criteria

* Being clinically unstable * Inability to cognitively participate in tests * Having received acupuncture treatment in the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Timed 25 Foot Walk Test ScoreBaseline, after 1 month and 3 month changesThe Timed 25 Foot Walk test assesses a patient's ability to walk 25 feet distance.Patient's walking speed in m/s calculate

Secondary

MeasureTime frameDescription
Neurogenic Bladder Symptom ScoringBaseline, after 1 month and 3 month changesThe Neurogenic Bladder Symptom Score (NBSS) is a validated 24 item questionnaire that measures bladder symptoms across 3 different domains: incontinence (scored 0-29), storage and voiding (scored 0-22), and consequences (scored 0-23); there is a single general urinary QOL question scored from 0 (pleased) to 4 (unhappy). For all domains, a higher score represents a worse symptom burden or QOL
Incontinence Quality of Life QuestionnaireBaseline, after 1 month and 3 month changesThere are 22 questions. The 22 items can be further grouped into 3 subscales: Avoidance and Limiting Behaviour (8 items), Psychosocial Impacts (9 items), and Social Embarrassment (5 items). The total I-QOL and 3 subscale scores are calculated by summing the unweighted item score and transforming them to a 100 point scale where 0 = most severe, and 100 = no problem . The instrument has been widely used and has been successfully validated for people with uriner incontinence
Multiple Sclerosis Quality of Life-54 (MSQOL-54)Baseline, after 1 month and 3 month changesThe MSQOL-54 is a multidimensional health-related quality of life measure that combines both generic and MS-specific items into a single instrument
Fatigue Severity ScaleBaseline, after 1 month and 3 month changesThe FAS is a 10-item scale evaluating symptoms of chronic fatigue. As the score increases in FAS, the severity of the patient's fatigue also increases.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026